Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-08-16
1992-02-25
Friedman, S. J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3147
Patent
active
050913913
ABSTRACT:
A method for resisting neurological damage caused by overstimulation of the MDA receptor of nerve cells by glutamate includes exposing the NMDA receptors to an oxidizing agent to thereby diminish overall activity of the receptors following activation by glutamate. The oxidizing agent preferably is a material selected from the group consisting of pyrroloquinoline quinone and topa hydantoin.
Aizenman Elias
Gallop Paul M.
Rosenberg Paul A.
Friedman S. J.
Silverman Arnold B.
University of Pittsburgh of the Commonwealth System of Higher Ed
LandOfFree
Method of resisting neurodegenerative disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of resisting neurodegenerative disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of resisting neurodegenerative disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1893137